Re-biopsy from bone metastatis lessio... - Advanced Prostate...

Advanced Prostate Cancer

23,005 members28,554 posts

Re-biopsy from bone metastatis lessions ? Will it pass proper DNA quality check for BRCA/HRR testing ??

pka21 profile image
5 Replies

We had our recent PSMA PET SCAN on 19th Mar, Dr. suggested to do re biospy this time to find out any treatable mutation since in last scan we did not get any feasible site. (Majority of standard care got failed/used)

Since nothing is in Prostate, my MO said its generally difficult to do biospy from bone lessions as per our scan and sometime we did not get proper DNA quality for testing, But for checking feasibility, Reffered to IR Dr. Who said they can do it.

But Nobody is giving any confidence that we will be benefitted from this and also my father is little scared of re biospy.

Can someone pls share their experience or thoughts on this?

Written by
pka21 profile image
pka21
To view profiles and participate in discussions please or .
Read more about...
5 Replies
Tall_Allen profile image
Tall_Allen

Even if there is no tailored therapy yet, there may be some in clinical trials.

pka21 profile image
pka21 in reply toTall_Allen

Thanks TA for the response!

MO planned to start Honovan and Nuclear Med Dr. gaved the option for Ac225 as further lu177 is not going to be benefitted.

For Ac225 also, waiting period is more than a month for med availability and it is costly as well.

Also Not sure how it will work after lu177 got failed , considering patient has many psma avid and many psma non avid sites present on psma pet scan.

Can Ac225 work in our case ?

Regarding clinical trail, As per Dr, there is no clinical trail going on in TMH and not sure about other places in India. Request ur help if you have any info on this please.

Tall_Allen profile image
Tall_Allen in reply topka21

I think PSMA-targeted radiotherapy is dangerous in men with discordant cancers. Some disagree.

prostatecancer.news/2019/12...

MateoBeach profile image
MateoBeach in reply topka21

What does Ishita Sen say?

ishitasen profile image
ishitasen in reply topka21

We have treated a number of patients with Ac225 following failure with lu177. There is usually a fairly good response with a median duration of progression free survival in bone only disease of about 8 - 9 months. The problem with Ac225 is the salivary gland toxicity and the cost. Also to some extent the availability. The Ac225 supply chain will likely improve after about 6 months, till then supply is extremely restricted

Not what you're looking for?

You may also like...

PSMA, Axumin, or .......?

Hi dear friends...We are currently in a delemma....In our consult with Dr. Scholz, Rob was advised...
4luvofrob profile image

1st dose of Lu177 PSMA Therapy at Fortis Memorial, Gurugram, India Complete and Looking Very Promising!

Good morning from India. Charlie and I wanted to share that he feels great after his first...
paige20180 profile image

NVA PC Doctors

Hi Everyone...I am back again...Still seeking the best doctor for Rob, since he is losing Dr. Myers...
4luvofrob profile image

Elgie New Doctor Referral

Hi Everyone, I truly hope you're all feeling well. I think of all of you every single day. Life...
erjlg3 profile image

Elgie Starting Xtandi

Hi Everyone! We arrived home from our visit to dr. Myers yesterday and we saw dr. Myers yesterday....
erjlg3 profile image

Moderation team

Bethishere profile image
BethishereAdministrator
Number6 profile image
Number6Administrator
Darryl profile image
DarrylPartner

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.